These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 29250983)

  • 21. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes.
    Shen DW; Pouliot LM; Hall MD; Gottesman MM
    Pharmacol Rev; 2012 Jul; 64(3):706-21. PubMed ID: 22659329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDK7 inhibition suppresses aberrant hedgehog pathway and overcomes resistance to smoothened antagonists.
    Liu F; Jiang W; Sui Y; Meng W; Hou L; Li T; Li M; Zhang L; Mo J; Wang J; Zhao Y; Zhang L; Ma J; Tang Y
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12986-12995. PubMed ID: 31182587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance.
    Zhou Y; Sun W; Qin Z; Guo S; Kang Y; Zeng S; Yu L
    Biochem Pharmacol; 2021 Jul; 189():114228. PubMed ID: 32976832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of apoptosis in cancer development and treatment: focusing on the development and treatment of hematologic malignancies.
    Zivny J; Klener P; Pytlik R; Andera L
    Curr Pharm Des; 2010 Jan; 16(1):11-33. PubMed ID: 20214615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surmounting cancer drug resistance: New insights from the perspective of N
    Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
    Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Farnesyl transferase inhibitors.
    Li T; Sparano JA
    Cancer Invest; 2008 Aug; 26(7):653-61. PubMed ID: 18665473
    [No Abstract]   [Full Text] [Related]  

  • 27. The caveolin-1 connection to cell death and survival.
    Quest AF; Lobos-González L; Nuñez S; Sanhueza C; Fernández JG; Aguirre A; Rodríguez D; Leyton L; Torres V
    Curr Mol Med; 2013 Feb; 13(2):266-81. PubMed ID: 23228128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetics in cancer stem cells.
    Toh TB; Lim JJ; Chow EK
    Mol Cancer; 2017 Feb; 16(1):29. PubMed ID: 28148257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mathematical models of cell phenotype regulation and reprogramming: Make cancer cells sensitive again!
    Wooten DJ; Quaranta V
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):167-175. PubMed ID: 28396217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer cells undergoing epigenetic transition show short-term resistance and are transformed into cells with medium-term resistance by drug treatment.
    Poojan S; Bae SH; Min JW; Lee EY; Song Y; Kim HY; Sim HW; Kang EK; Kim YH; Lee HO; Hong Y; Park WY; Jang H; Hong KM
    Exp Mol Med; 2020 Jul; 52(7):1102-1115. PubMed ID: 32661348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.
    Easwaran H; Tsai HC; Baylin SB
    Mol Cell; 2014 Jun; 54(5):716-27. PubMed ID: 24905005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The amino acid metabolism is essential for evading physical plasma-induced tumour cell death.
    Gandhirajan RK; Meyer D; Sagwal SK; Weltmann KD; von Woedtke T; Bekeschus S
    Br J Cancer; 2021 May; 124(11):1854-1863. PubMed ID: 33767419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addressing intra-tumoral heterogeneity and therapy resistance.
    Rybinski B; Yun K
    Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of acquired resistance to targeted cancer therapies.
    Lackner MR; Wilson TR; Settleman J
    Future Oncol; 2012 Aug; 8(8):999-1014. PubMed ID: 22894672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transposable element regulation and expression in cancer.
    Grundy EE; Diab N; Chiappinelli KB
    FEBS J; 2022 Mar; 289(5):1160-1179. PubMed ID: 33471418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance.
    Bacci M; Lorito N; Smiriglia A; Morandi A
    Trends Cancer; 2021 Mar; 7(3):198-213. PubMed ID: 33281098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy.
    Lu Y; Chan YT; Tan HY; Li S; Wang N; Feng Y
    Mol Cancer; 2020 Apr; 19(1):79. PubMed ID: 32340605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapeutic approaches for targeting cell death pathways.
    Ricci MS; Zong WX
    Oncologist; 2006 Apr; 11(4):342-57. PubMed ID: 16614230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small-molecular modulators of cancer-associated epigenetic mechanisms.
    Itoh Y; Suzuki T; Miyata N
    Mol Biosyst; 2013 May; 9(5):873-96. PubMed ID: 23511667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Dual Roles of NRF2 in Cancer.
    Menegon S; Columbano A; Giordano S
    Trends Mol Med; 2016 Jul; 22(7):578-593. PubMed ID: 27263465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.